A look at the cumulative effect of diagnostic steps for primary tumor identification in patients with head and neck squamous cell carcinoma of unknown primary.
![](https://www.enttoday.org/wp-content/uploads/2019/07/ENT_0719_pg10b-1024x343.png)
A look at the cumulative effect of diagnostic steps for primary tumor identification in patients with head and neck squamous cell carcinoma of unknown primary.
How sensitive is single-photon emission computed tomography/computed tomography (SPECT/CT) in sentinel lymph node biopsy (SLNB) for cutaneous malignancies of the head and neck?
Surgeons, oncologists at Triological Combined Sections Meeting discuss role of imaging, recurrence management, nonsurgical options for patients
Panelists at Triological Combined Sections Meeting explore ways genetics, molecular diagnostics can impact head and neck cancer therapy
Accuracy, diagnostic value of in-office biopsies versus direct microlaryngoscopy
Study finds genetic alterations act together to produce more aggressive tumors in head and neck cancers.
Best practices support active role for speech language pathologists for head and neck cancer patients at point of diagnosis
How do survival estimates for transoral robotic surgery (TORS) compare to intensity-modulated radiotherapy (IMRT) for early T-stage oropharyngeal cancer?
Does surgeon and/or institution resection volume predict long-term overall survival in head and neck cancer in a publicly funded healthcare system?
Does detection of the occult primary tumor result in improved survival in head and neck sqamous cell carcinoma?